Needham & Company
-
Histogenics Corporation to Present at the 14th Annual Needham Healthcare Conference
-
Needham & Company Starts Histogenics Corp. (HSGX) at Buy
-
Histogenics (HSGX) IPO Opens Higher after Weak Pricing
-
Histogenics (HSGX) IPO Prices at $11, Below Expected Range
-
Histogenics Corporation Announces Pricing of Initial Public Offering